Intellia Therapeutics
NTLA
#5466
Rank
NZ$2.56 B
Marketcap
NZ$18.28
Share price
5.04%
Change (1 day)
25.02%
Change (1 year)

Market capitalization of Intellia Therapeutics (NTLA)

Market cap: NZ$2.56 Billion

As of November 2026 Intellia Therapeutics has a market cap of NZ$2.56 Billion. This makes Intellia Therapeutics the world's 5466th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intellia Therapeutics from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$2.56 B35.9%
2025NZ$1.88 B-12.66%
2024NZ$2.16 B-49.93%
2023NZ$4.31 B-8.87%
2022NZ$4.73 B-63.22%
2021NZ$12.88 B164.53%
2020NZ$4.87 B345.39%
2019NZ$1.09 B18.81%
2018NZ$0.92 B-19.67%
2017NZ$1.14 B68.18%
2016NZ$0.68 B

End of Day market cap according to different sources

On Nov 21st, 2026 the market cap of Intellia Therapeutics was reported to be:

NZ$2.56 Billion
by Nasdaq info icon info icon
NZ$2.56 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.39 B-45.50%๐Ÿ‡บ๐Ÿ‡ธ USA